Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Endocrine 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 958Urinary Bladder Neoplasms 264Carcinoma, Renal Cell 251Kidney Neoplasms 146Carcinoma, Transitional Cell 130Breast Neoplasms 128Neoplasms 122Colorectal Neoplasms 97Ovarian Neoplasms 91Melanoma 86Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 81Neoplasm Metastasis 79Pancreatic Neoplasms 68Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 58Stomach Neoplasms 55Head and Neck Neoplasms 51Squamous Cell Carcinoma of Head and Neck 47Endometrial Neoplasms 47Adenocarcinoma 46Esophageal Neoplasms 44Testicular Neoplasms 42Sarcoma 41Carcinoma, Hepatocellular 41Disease 33Triple Negative Breast Neoplasms 32Liver Neoplasms 30Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Angiomyolipoma × Genitourinary × Clear all
NCT06683846 2025-08-24

Ivonescimab in the Treatment of Multiple Advanced Tumors

Fudan University

Phase 2 Recruiting
400 enrolled
CNSDermatologicEndocrineGenitourinarySarcoma

Urachal cancer, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Transitional Cell, Kidney Neoplasms, Paget Disease, Extramammary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Prostatic Neoplasms, Rhabdomyosarcoma, Sarcoma, Angiomyolipoma, Carcinoma, Neuroendocrine, Perivascular Epithelioid Cell Neoplasms

NCT05785052 2023-03-27

BRC

Biorek S.R.L.

Recruiting
1,000 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms, Angiomyolipoma, Adenoma, Oxyphilic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡